Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat
- 1 December 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 19 (12), 1359-1368
- https://doi.org/10.1089/hum.2008.123
Abstract
Heart disease is the leading cause of morbidity and mortality. Cardiac gene transfer may serve as a novel therapeutic approach. This investigation was undertaken to compare cardiac tropisms of adeno-associated virus (AAV) serotypes 1, 6, 7, 8, and 9. Neonatal mice were injected with 2.5 × 1011 genome copies (GC) of AAV serotype 1, 6, 7, 8, or 9 expressing LacZ under the control of the constitutive chicken β-actin promoter with cytomegalovirus enhancer promoter via intrapericardial injection and monitored for up to 1 year. Adult rats were injected with 5 × 1011 GC of the AAV vectors via direct cardiac injection and monitored for 1 month. Cardiac distribution of LacZ expression was assessed by X-Gal histochemistry, and β-galactosidase activity was quantified in a chemiluminescence assay. Cardiac functional data and biodistribution data were also collected in the rat. AAV9 provided global cardiac gene transfer stable for up to 1 year that was superior to other serotypes. LacZ expression was relatively cardiac specific, and cardiac function was unaffected by gene transfer. AAV9 provides high-level, stable expression in the mouse and rat heart and may provide a simple alternative to the creation of cardiac-specific transgenic mice. AAV9 should be used in rodent cardiac studies and may be the vector of choice for clinical trials of cardiac gene transfer.Keywords
This publication has 31 references indexed in Scilit:
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic InjectionMolecular Therapy, 2008
- Efficient and Durable Gene Transfer to Transplanted Heart Using Adeno-associated Virus 9 VectorThe Journal of Heart and Lung Transplantation, 2008
- AAV‐mediated knockdown of phospholamban leads to improved contractility and calcium handling in cardiomyocytesThe Journal of Gene Medicine, 2007
- Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transductionGene Therapy, 2007
- Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure RescueCirculation, 2007
- Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteinsJournal of Molecular and Cellular Cardiology, 2007
- Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyJournal of Thrombosis and Haemostasis, 2006
- Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In VivoCirculation Research, 2006
- Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectorsCardiovascular Research, 2006
- Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisGene Therapy, 2001